TREAT-AD: TaRget Enablement to Accelerate Therapy Development for AD

There is a newer version of the record available.

Published May 18, 2022 | Version v1
Report Open

IUSM-Purdue TREAT-AD Center Target Enabling Component PLCG2 Expression and Purification

Authors/Creators

  • 1. Purdue University

Description

A Target Enabling Component detailing protein expression and purification for PLCG2 constructs 

Files

Protein expression and purification target enabling component placeholder.pdf

Files (140.4 kB)